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Abstract
Background: Helicobacter pylori remains a global health hazard, and vaccination would be ideal
for its control. Natural infection appears not to induce protective immunity. Thus, the feasibility
of a vaccine for humans is doubtful. Methods: In two prospective, randomised, double-blind,
controlled studies (Paul Ehrlich Institute application nos 0802/02 and 1097/01), live vaccines
against H pylori were tested in human volunteers seronegative for, and without evidence of,
active H pylori infection. Volunteers (n = 58) were immunised orally with Salmonella enterica
serovar Typhi Ty21a expressing H pylori urease or HP0231, or solely with Ty21a, and then
challenged  with  2×105  cagPAI-  H  pylori.  Adverse  events,  infection,  humoral,  cellular  and
mucosal  immune response  were  monitored.  Gastric  biopsies  were  taken  before  and  after
vaccination,  and postchallenge. Infection was terminated with antibiotics.  Results:  Vaccines
were  well  tolerated.  Challenge  infection  induced  transient,  mild  to  moderate  dyspeptic
symptoms, and histological and transcriptional changes in the mucosa known from chronic
infection.  Vaccines  did  not  show satisfactory  protection.  However,  13  of  58  volunteers,  8
vaccinees  and  5  controls,  became breath  test  negative  and  either  cleared  Hpylori  (5/13)
completely or reduced the H pylori burden (8/13). H pylori-specific T helper cells were detected
in 9 of these 13 (69%), but only in 6 of 45 (13%) breath test-positive volunteers (p = 0.0002;
Fisher  exact  test).  T  cells  were  either  vaccine  induced or  pre-existing,  depending  on  the
volunteer.  Conclusion:  Challenge  infection  offers  a  controlled  model  for  vaccine  testing.
Importantly, it  revealed evidence for T cell-mediated immunity against H pylori infection in
humans.
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